Abstract
NEW YORK – Oncocyte said Monday that it has entered a securities purchase agreement for a registered direct offering and concurrent private placement that is expected to raise $29.1 million in gross proceeds.
Key Data
-
Publication Date10 February 2025
-
Primary Author360Dx
-
Source360Dx
-
LanguageEnglish
Click below to visit original source: